Titlebook: Non-coding RNAs in Cardiovascular Diseases; Junjie Xiao Book 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license

良心

Tarik Smani,Isabel Mayoral-Gonzalez,Isabel Galeano-Otero,Isabel Gallardo-Castillo,Juan A. Rosado,Ant

VALID

An Overview of Non-coding RNAs and Cardiovascular Systemhorizon in the field of molecular medicines and in the development of early diagnostic markers. Non-coding RNAs are the highly functional and vibrant nucleic acids and are known to be involved in the regulation of endothelial cells, vascular and smooth muscles cells, cardiac metabolism, ischemia, in

荒唐

Bioinformatics Research Methodology of Non-coding RNAs in Cardiovascular Diseasesof pathologies. In cardiovascular diseases, the role of specific families of RNA transcripts belonging to the group of the non-coding RNAs started to be unveiled in the last two decades. The knowledge of the functional rules and roles of non-coding RNAs in the context of cardiovascular diseases is a

Minutes

火光在搖曳

客觀

flutter

Involvement of Epigenetic Control and Non-coding RNAs in Cardiovascular Systemng to pathophysiology and genetics of CVDs have helped in prevention, diagnosis and treatment of diseases, there are still lacunas in our knowledge. So, novel tools that can define genomic regulation under different conditions are needed to bridge this gap. ‘Epigenetic’ mechanism helps the cells to

Institution

Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseasesng normal or specific developmental stages of the organisms. Primarily, three different mechanisms have been identified to participate in epigenetic gene regulations which include, DNA methylation, non-coding RNA species (microRNAs [miRNA], and long non-coding RNAs [LNC-RNA]) and histone modificatio

Substance-Abuse

Non-coding RNAs in Physiological Cardiac Hypertrophyon, RNA maturation and protein translation, participating in a variety of physiological and physiological processes. NcRNAs have important functions, and are recently one of the hotspots in biomedical research. Cardiac hypertrophy is classified into physiological cardiac hypertrophy and pathological

長(zhǎng)矛